GENE ONLINE|News &
Opinion
Blog

Deals
Trailhead Biosystems Raises $6.6 Million in Series A Financing
2020-11-12
Novo Nordisk’s Acquisition of Emisphere Could Embolden Diabetics to Cut Back on Needles
2020-11-08
Hot Pursuit for Antibody Drug Conjugates Continue as Merck Acquires VelosBio
2020-11-06
Aiming for the First CAR-T Approval in China, JW Therapeutics Debuts on Hong Kong Stock Exchange
2020-11-04
Sanofi Offers to Buy Kiadis Pharma to Advance Immuno-Oncology Research
2020-11-03
Why is PerkinElmer Buying Horizon Discovery?
2020-11-02
Novartis Expands Foothold in Gene Therapy With New Acquisition
2020-10-30
IPO
Drawing Millions in Investment, RemeGen is Ready to Bag 514m in IPO
2020-10-29
A Rising Star in Chinese Pharma Industry Marks Market Debut in Hong Kong
2020-10-29
Exact Sciences Looks to Thrive in Blood-Based, Early Cancer Detection Space with Two New Buyouts
2020-10-29
Scorpion Therapeutics Scores $108 Million Series A Funding for Oncological Research
2020-10-28
Pfizer Expands Antibacterial Portfolio by Acquiring Antibiotic Drug Maker
2020-10-28
Is Bayer’s Entry to the Gene Therapy Market Worth it’s Investment?
2020-10-27
Retrophin Acquires Orphan Technologies to Develop Potential, Effective Cure for Rare Disease
2020-10-25
Maryland Biopharma Raises $105 Million in Series D to Fund Development of RNAi Therapeutics
2020-10-24
1 39 40 41 42 43 47
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top